Bioinformatics Market
Bioinformatics Market Analysis by Platforms and Services for Genomics, Proteomics, Transcriptomics, and Chemoinformatics from 2024 to 2034
Analysis of Bioinformatics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Bioinformatics Market Outlook (2024 to 2034)
The global bioinformatics market size has been estimated at US$ 14.29 billion for 2024 and is forecasted to reach a valuation of US$ 50.25 billion by 2034, expanding rapidly at a CAGR of 13.4% over the next ten years. The market represents the dynamic convergence of biology and technology, offering critical tools and insights for comprehending complicated biological data. This rapidly developing discipline employs computational tools to decode, manage, and interpret massive amounts of biological data, especially genomic data, proteomics, and metabolomics.
Artificial intelligence (AI) and machine learning are set to play a crucial role in bioinformatics. These tools can automate data analysis, reveal trends in the bioinformatics market, and deliver insights that older methods may not provide. Single-cell sequencing technologies enable the study of individual cells, yielding previously impossible levels of clarity and insights. Data from genomes, proteomics, metabolomics, and other omics disciplines are predicted to be combined to provide complete knowledge of complicated biological processes.
Important Market Growth Drivers
- Bioinformatics is critical for managing and interpreting the vast genetic datasets that are being generated. Demand for bioinformatics tools and services rises as a result.
- Analyzing genetic data enables healthcare professionals to make data-driven treatment decisions, improving efficacy and lowering unwanted effects.
- Bioinformatics is critical in the pharmaceutical sector for target identification, lead optimization, and clinical trial design.
- Predictive analytics based on genetic data speeds up drug discovery, lowers development costs, and reduces clinical trial failures.
- Bioinformatics is important in many areas of biological research, including gene expression analysis, protein-protein interaction investigations, and pathway analysis.
Bioinformatics technologies are used by researchers to derive valuable insights from complex biological data. There is an increasing demand for people with bioinformatics experience, yet there is a shortage of trained talent in this industry. Bridging this skills gap is critical for the continued growth of the market.
| Report Attributes | Details |
|---|---|
| Bioinformatics Market Size (2023A) | US$ 12.6 Billion |
| Estimated Market Value (2024E) | US$ 14.29 Billion |
| Forecasted Market Value (2034F) | US$ 50.25 Billion |
| Global Market Growth Rate (2024 to 2034) | 13.4% CAGR |
| North America Market Share (2023) | 44.7% |
| Europe Market Growth Rate (2024 to 2034) | 14.8% CAGR |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Pushing Global Demand for Bioinformatics?
“Rising Adoption of High-Throughput Sequencing Technologies”
Explosion of biological data created by high-throughput sequencing technologies, notably next-generation sequencing (NGS), is responsible for the existence and significance of the field. These technologies have transformed genomics research by enabling rapid, cost-effective, and comprehensive genome, transcriptome, and other biological entity sequencing. Bioinformatics provides a link for scientists and researchers to navigate the huge genomic landscape. It is required for genome assembly, variant calling, functional annotation, and comparative genomics.
Genomic technologies have improved our understanding of genetic diversity, disease causes, and evolutionary processes through the use of bioinformatics. The ongoing growth and advancement of genomic technology promise even larger datasets in the future, emphasizing the importance of bioinformatics in making sense of this gold mine of genetic information.
“Increasing Reliance on Bioinformatics in Research and Development Activities”
The pharmaceutical industry is in desperate need of new and cost-effective technologies to accelerate drug development, optimize lead compounds, and improve clinical trial outcomes. Bioinformatics provides sophisticated tools and methodologies for evaluating biological data, hence speeding the drug development workflow.
Bioinformatics in pharmaceutical R&D facilitates target discovery by sifting through massive databases to identify prospective therapeutic targets. It is crucial in lead optimization, assisting in the identification of the most promising drug candidates based on their interactions with biological targets. Bioinformatics supports clinical trial design by optimizing patient cohort selection and data analysis to improve trial outcomes. Bioinformatics minimizes the likelihood of late-stage failures by predicting medication interactions, toxicity, and efficacy. It enables pharmaceutical businesses to make data-driven decisions, favoring molecules with a greater chance of success.
What is Hampering the Bioinformatics Market Worth?
“High Investment Cost Limiting Scope and Potential for Innovation”
Building and maintaining the required infrastructure, which includes powerful computer capabilities and data storage, necessitates significant financial resources. To handle the huge quantities created by genomics and other biological studies, high-performance computing clusters, storage solutions, and professional IT staff are required. Acquiring and maintaining cutting-edge bioinformatics software can be costly. For smaller research institutions, start-ups, and underfunded initiatives, the expense of procuring, installing, and maintaining bioinformatics tools can be a considerable barrier. This disparity in resource access can slow down the rate of innovation and research breakthroughs. The rapid advancement of bioinformatics technologies demands ongoing investment to remain competitive.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How Can New Companies Contribute to the Future of the Bioinformatics Industry?
“Start-ups Benefitting from Focus on User-centric Design and Data Security”
Start-ups can achieve a strategic advantage in the highly competitive and fast-expanding bioinformatics industry by focusing on specialization, promoting innovation, and forming strong relationships. They can supply unique answers and insights to a specific client’s needs by becoming specialists in a specific sector of bioinformatics. Continuous R&D activities should support their pursuit of innovation, resulting in unique bioinformatics platforms or tools that stand out.
Prioritizing user-centric design, data security, and customer involvement also improves the customer experience and creates trust, while scalability ensures that their solutions can adapt to the changing demands of the market. Start-ups that remain agile, adopt changing technologies and use efficient marketing and branding tactics can maintain their place in the competitive bioinformatics scene and contribute to advances in this crucial field of science and technology.
Country-wise Insights
Fact.MR, a market research and competitive intelligence provider, reveals that North America is the leading region in the global market for bioinformatics business, with markets in Asia Pacific and Europe expanding at an impressive pace.
What are the Opportunities for Players in the Bioinformatics Business in the United States?
“Substantial Government Funding and Robust Biotechnology Sector”
North America accounted for 44.7% of the global bioinformatics market share in 2023 and is projected to expand at a CAGR of 12.7% over the forecast period. The United States is home to several prominent bioinformatics firms, research organizations, and academic centers, making it a focus for innovation and development.
Top companies in the bioinformatics market with headquarters in the United States include Thermo Fisher Scientific, Illumina Inc., and the Broad Institute, providing a competitive and inventive atmosphere.
Government initiatives and significant financing are essential in accelerating bioinformatics research and development. The National Institutes of Health (NIH) and the National Human Genome Research Institute (NHGRI) have continually committed large sums of money to genomics research, establishing the groundwork for the expansion of bioinformatics applications.
Investments enable cutting-edge research, the creation of cutting-edge tools, and the translation of discoveries into practical solutions for the healthcare and life sciences industries. Bioinformatics is essential to achieving precision medicine goals because it simplifies the analysis and interpretation of large datasets, ultimately leading to more tailored and effective patient care.
The burgeoning biotechnology instruments sector in the United States fuels the need for bioinformatics solutions. As bioinformatics becomes more important in genome research, personalized medicine, and drug discovery, the United States is poised to remain at the forefront of advancements in this interdisciplinary subject, contributing to its global expansion and innovation.
Which Factors are Responsible for the Development of the Bioinformatics Industry in India?
“Rapid Adoption of Bioinformatics in Healthcare Sector”
The market in Asia Pacific is projected to advance at a CAGR of 19% from 2024 to 2034. India has seen significant expenditures in genomics research and biotechnology. Government initiatives and funding have accelerated the growth of genomics and bioinformatics research institutions and biotech enterprises. This investment has resulted in a strong ecosystem for the application of bioinformatics.
With millions of genomes from various ethnic groups and genetic backgrounds, India is an excellent supply of data for bioinformatics research. This diversity not only aids in understanding genetic variations but also establishes India as a center for pharmacogenomics research, in which pharmaceuticals are tailored to the genetic makeup of an individual. Because bioinformatics tools and services are required for maintaining and interpreting genetic data, this adoption is anticipated to generate demand for them. As demand for bioinformatics solutions grows in India, the role of the country in defining the future of healthcare and life sciences through data-driven biology is poised to grow on a worldwide scale.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Based on application, the genomics segment is projected to grow at a significant pace through the forecast period. The medical biotechnology segment is forecasted to expand at a high-value CAGR of 9% through 2034.
Why Does the Services Segment Occupy a Leading Share of the Market?
“Bioinformatics Services Enabling Enterprises to Offer Tailored Solutions”
The bioinformatics services segment is forecasted to expand at a CAGR of 18% through 2034. Bioinformatics services provide a wide range of solutions adapted to the individual demands of research institutes, biotechnology and pharmaceutical services businesses, and healthcare providers. These services include data analysis, interpretation, and consulting to help clients make educated decisions in genomics, drug discovery, and customized medicine. The intricacy of biological data necessitates proficiency in handling and deriving valuable insights from it, underscoring the significance of services as a crucial component of the industry.
The bioinformatics services segment provides enterprises with flexibility and scalability. Unlike products, which are frequently one-size-fits-all, services can be tailored to solve specific research topics or issues. Bioinformatics services offer tailored solutions that can significantly accelerate research and development efforts, whether they are used by a genomics research team to analyze massive datasets or by a pharmaceutical business to optimize its drug discovery pipeline.
Bioinformatics is a rapidly evolving science, with new tools and approaches appearing all the time. Services providers are well-positioned to keep up with these developments, ensuring that their clients have access to the most up-to-date and effective solutions. This is especially useful in genomics, where technology such as next-generation sequencing is constantly evolving and necessitates current bioinformatics understanding.
Competitive Landscape
The competitive landscape of the market is distinguished by a dynamic interaction of established corporations, start-ups, and academic institutions. With their complete bioinformatics solutions, key firms such as Thermo Fisher Scientific, Illumina Inc., PerkinElmer Inc., BGI Group, and QIAGEN lead the market.
- Thermo Fisher Scientific, a leader in life sciences solutions, provides a suite of bioinformatics tools for genomics research.
- Illumina, best known for its DNA sequencing technology, augments its platforms with bioinformatics tools to aid in data processing.
- PerkinElmer offers a wide range of genomics and life sciences software and services.
- QIAGEN specializes in sample and assay technologies and provides bioinformatics solutions for data processing and interpretation.
Simultaneously, a thriving start-up environment is pumping new life into the market. These firms focus on specific aspects of bioinformatics, such as single-cell sequencing analysis, epigenetics, or structural bioinformatics, providing specialized solutions and tackling unique challenges. Their agility and innovative techniques give them a competitive advantage, allowing them to carve out distinct market areas.
Segmentation of Bioinformatics Market Research
-
By Product Type :
- Bioinformatics Platforms
- Bioinformatics Services
-
By Application :
- Genomics
- Chemoinformatics
- Proteomics
- Transcriptomics
- Others
-
By Deployment :
- Medical Biotechnology
- Animal Biotechnology
- Agriculture Biotechnology
- Academics
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Global Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Impact Benchmark with Previous Crisis 3.1.1.1. Change in Demand 3.1.1.2. Before and After COVID-19 Crisis (Projected) 3.1.1.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.1.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.2. Impact on Market and Value (US$ Mn) 3.1.2.1. Likely Loss of Value in 2023 3.1.2.2. Mid-term and Long-term Forecasts 3.1.2.3. Quarter by Quarter Demand and Recovery Assessment 3.1.3. Anticipated Demand and Value Recovery Curve 3.1.3.1. Likelihood of U-Shape Recovery 3.1.3.2. Likelihood of L-Shape Recovery 3.1.4. Recovery Period Assessment by Key Countries 3.1.5. Recovery Assessment by Key Market Segments 3.1.6. Action Points and Recommendations for Suppliers 3.1.7. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Application Development Trends 4. Market Background and Foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Bioinformatics 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034 5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2023 5.2. Current and Future Market Value (US$ Mn) Projections, 2024 to 2034 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Application, 2018 to 2023 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2024 to 2034 6.3.1. Genomics 6.3.2. Chemoinformatics 6.3.3. Proteomics 6.3.4. Transcriptomics 6.3.5. Others 6.4. Market Attractiveness Analysis By Application 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Product Type 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Product Type, 2018 to 2023 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product Type, 2024 to 2034 7.3.1. Platforms 7.3.2. Services 7.4. Market Attractiveness Analysis By Product Type 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Deployment 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By Deployment, 2018 to 2023 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Deployment, 2024 to 2034 8.3.1. Medical Biotechnology 8.3.2. Animal Biotechnology 8.3.3. Agriculture Biotechnology 8.3.4. Academics 8.4. Market Attractiveness Analysis By Deployment 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2023 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 10.3.1. By Country 10.3.1.1. United States 10.3.1.2. Canada 10.3.2. By Application 10.3.3. By Product Type 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Application 10.4.3. By Product Type 11. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Application 11.3.3. By Product Type 11.3.4. By Deployment 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Application 11.4.3. By Product Type 11.4.4. By Deployment 12. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. United Kingdom 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Application 12.3.3. By Product Type 12.3.4. By Deployment 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Application 12.4.3. By Product Type 12.4.4. By Deployment 13. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Application 13.3.3. By Product Type 13.3.4. By Deployment 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Application 13.4.3. By Product Type 13.4.4. By Deployment 14. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Application 14.3.3. By Product Type 14.3.4. By Deployment 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Application 14.4.3. By Product Type 14.4.4. By Deployment 15. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Application 15.3.3. By Product Type 15.3.4. By Deployment 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Application 15.4.3. By Product Type 15.4.4. By Deployment 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. PerkinElmer, Inc. 17.3.1.1. Company Overview 17.3.1.2. Application overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. Biomax Informatics AG 17.3.2.1. Company Overview 17.3.2.2. Application overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. Intrexon Germany GmbH 17.3.3.1. Company Overview 17.3.3.2. Application overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Genedata AG 17.3.4.1. Company Overview 17.3.4.2. Application overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. Agilent Technologies, Inc. 17.3.5.1. Company Overview 17.3.5.2. Application overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. Dnanexus, Inc. 17.3.6.1. Company Overview 17.3.6.2. Application overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. Seven Bridges Genomics Inc. 17.3.7.1. Company Overview 17.3.7.2. Application overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. Agilent Technologies 17.3.8.1. Company Overview 17.3.8.2. Application overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Illumina Inc. 17.3.9.1. Company Overview 17.3.9.2. Application overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. QIAGEN N. V. 17.3.10.1. Company Overview 17.3.10.2. Application overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 17.3.11. Thermo Fisher Scientific Inc. 17.3.11.1. Company Overview 17.3.11.2. Application overview 17.3.11.3. SWOT Analysis 17.3.11.4. Key Developments 17.3.12. Dassault Systèmes 17.3.12.1. Company Overview 17.3.12.2. Application overview 17.3.12.3. SWOT Analysis 17.3.12.4. Key Developments 18. Assumptions and Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Deployment, 2018 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Deployment, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Deployment, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Deployment, 2018 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Deployment, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Deployment, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by Deployment, 2018 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by Deployment, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Deployment, 2024 to 2034
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Europe Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 41: Europe Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 43: Europe Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 44: Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 46: Europe Market Value (US$ Mn) Analysis, by Deployment, 2018 to 2023
Table 47: Europe Market Value (US$ Mn) Analysis, by Deployment, 2024 to 2034
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Deployment, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 58: East Asia Market Value (US$ Mn) Analysis, by Deployment, 2018 to 2023
Table 59: East Asia Market Value (US$ Mn) Analysis, by Deployment, 2024 to 2034
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Deployment, 2024 to 2034
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Deployment, 2018 to 2023
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Deployment, 2024 to 2034
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Deployment, 2024 to 2034
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: MEA Market Value (US$ Mn) Analysis, by Application, 2018 to 2023
Table 77: MEA Market Value (US$ Mn) Analysis, by Application, 2024 to 2034
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2024 to 2034
Table 79: MEA Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 80: MEA Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 82: MEA Market Value (US$ Mn) Analysis, by Deployment, 2018 to 2023
Table 83: MEA Market Value (US$ Mn) Analysis, by Deployment, 2024 to 2034
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Deployment, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Application, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Application, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Deployment, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Deployment, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Deployment, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Deployment, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Deployment, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Deployment, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Application, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Application, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by Deployment, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by Deployment, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Deployment, 2024 to 2034
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Europe Market Share and BPS Analysis by Application, 2024 & 2034
Figure 57: Europe Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 58: Europe Market Attractiveness Analysis by Application, 2024 to 2034
Figure 59: Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 60: Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 61: Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 62: Europe Market Share and BPS Analysis by Deployment, 2024 & 2034
Figure 63: Europe Market Y-o-Y Growth Projections by Deployment, 2024 to 2034
Figure 64: Europe Market Attractiveness Analysis by Deployment, 2024 to 2034
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 72: East Asia Market Share and BPS Analysis by Application, 2024 & 2034
Figure 73: East Asia Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 74: East Asia Market Attractiveness Analysis by Application, 2024 to 2034
Figure 75: East Asia Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 76: East Asia Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 77: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 78: East Asia Market Share and BPS Analysis by Deployment, 2024 & 2034
Figure 79: East Asia Market Y-o-Y Growth Projections by Deployment, 2024 to 2034
Figure 80: East Asia Market Attractiveness Analysis by Deployment, 2024 to 2034
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Application, 2024 & 2034
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Application, 2024 to 2034
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 94: South Asia & Oceania Market Share and BPS Analysis by Deployment, 2024 & 2034
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Deployment, 2024 to 2034
Figure 96: South Asia & Oceania Market Attractiveness Analysis by Deployment, 2024 to 2034
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 101: MEA Market Share Analysis by Country, 2024 & 2034
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 104: MEA Market Share and BPS Analysis by Application, 2024 & 2034
Figure 105: MEA Market Y-o-Y Growth Projections by Application, 2024 to 2034
Figure 106: MEA Market Attractiveness Analysis by Application, 2024 to 2034
Figure 107: MEA Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 108: MEA Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 109: MEA Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 110: MEA Market Share and BPS Analysis by Deployment, 2024 & 2034
Figure 111: MEA Market Y-o-Y Growth Projections by Deployment, 2024 to 2034
Figure 112: MEA Market Attractiveness Analysis by Deployment, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the projected sales value of bioinformatics solutions in 2024?
Sales of bioinformatics solutions are calculated at US$ 14.29 billion for 2024.
Which region held a leading share of the global market in 2023?
North America accounted for 44.7% share of the global bioinformatics market in 2023.
What is the demand projection for bioinformatics solutions by 2034?
Demand for bioinformatics solutions is projected to reach a market value of US$ 50.25 billion by 2034-end.
What is the sales growth projection for bioinformatics?
Revenue from the sales of bioinformatics solutions is projected to increase at a CAGR of 13.4% through 2034.
At what rate is the European market predicted to grow?
The European market is predicted to advance at a 14.8% CAGR through 2034.
What is the growth outlook for genomics through 2034?
The genomics application segment is predicted to expand at 11.85% CAGR from 2024 to 2034.
Bioinformatics Market